The soluble transcobalamin receptor (sCD320) is present in cerebrospinal fluid and correlates to dementia-related biomarkers tau proteins and amyloid-beta

References

• Black MM. Effects of vitamin B12 and folate deficiency on brain development in children. Food Nutr Bull 2008;29: S126–31.
   PubMed Web of Science ®Google Scholar
• Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006;5:949–60.
   PubMed Web of Science ®Google Scholar
• Tangney CC, Aggarwal NT, Li H, Wilson RS, Decarli C, Evans DA, Morris MC. Vitamin B12, cognition, and brain MRI measures: a cross-sectional examination. Neurology 2011;77:1276–82.
   PubMed Web of Science ®Google Scholar
• Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012;24:541–56.
   PubMed Web of Science ®Google Scholar
• Nielsen MJ, Rasmussen MR, Andersen CB, Nexo E, Moestrup SK. Vitamin B12 transport from food to the body's cells− a sophisticated, multistep pathway. Nat Rev Gastroenterol Hepatol 2012;9:345–54.
   PubMed Web of Science ®Google Scholar
• Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood 2009;113:186–92.
   PubMed Web of Science ®Google Scholar
• Arendt JF, Quadros EV, Nexo E. Soluble transcobalamin receptor, sCD320, is present in human serum and relates to serum cobalamin − establishment and validation of an ELISA. Clin Chem Lab Med 2012;50:515–9.
   Web of Science ®Google Scholar
• Abuyaman O, Andreasen BH, Kronborg C, Vittinghus E, Nexo E. The soluble receptor for vitamin B12 uptake (sCD320) increases during pregnancy and occurs in higher concentration in urine than in serum. PLoS One 2013; 8:e73110.
   PubMed Web of Science ®Google Scholar
• Arendt JF, Nexo E. Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. PLoS One 2012;7:e45979.
   PubMed Web of Science ®Google Scholar
• Lai SC, Nakayama Y, Sequeira JM, Wlodarczyk BJ, Cabrera RM, Finnell RH, Bottiglieri T, Quadros EV. The transcobalamin receptor knockout mouse: a model for vitamin B12 deficiency in the central nervous system. FASEB J 2013;27:2468–75.
   PubMed Web of Science ®Google Scholar
• Ariogul S, Cankurtaran M, Dagli N, Khalil M, Yavuz B. Vitamin B12, folate, homocysteine and dementia: are they really related? Arch Gerontol Geriatr 2005;40:139–46.
   PubMed Web of Science ®Google Scholar
• van Harten AC, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YA, van der Flier WM, Scheltens P. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 2011;49:353–66.
   PubMed Web of Science ®Google Scholar
• Frederiksen J, Kristensen K, Bahl JM, Christiansen M. Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis. Mult Scler 2012;18:592–9.
   PubMed Web of Science ®Google Scholar
• Buongiorno M, Compta Y, Marti MJ. Amyloid-beta and tau biomarkers in Parkinson's disease-dementia. J Neurol Sci 2011;310:25–30.
   PubMed Web of Science ®Google Scholar
• Jiang W, Nakayama Y, Sequeira JM, Quadros EV. Characterizing monoclonal antibodies to antigenic domains of TCblR/CD320, the receptor for cellular uptake of transcobalamin-bound cobalamin. Drug Deliv 2011;18:74–8.
   PubMed Web of Science ®Google Scholar
• Nexo E, Christensen AL, Petersen TE, Fedosov SN. Measurement of transcobalamin by ELISA. Clin Chem 2000;46:1643–9.
   PubMed Web of Science ®Google Scholar
• Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002;48: 561–2.
   PubMed Web of Science ®Google Scholar
• Morkbak AL, Heimdal RM, Emmens K, Molloy A, Hvas AM, Schneede J, Clarke R, Scott JM, Ueland PM, Nexo E. Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project. Clin Chem Lab Med 2005;43:1058–64.
   PubMed Web of Science ®Google Scholar
• Mulugeta E, Londos E, Ballard C, Alves G, Zetterberg H, Blennow K, Skogseth R, Minthon L, Aarsland D. CSF amyloid beta38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2011; 82:160–4.
   PubMed Web of Science ®Google Scholar
• Bjerke M, Portelius E, Minthon L, Wallin A, Anckarsater H, Anckarsater R, Andreasen N, Zetterberg H, Andreasson U, Blennow K. Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimers Dis 2010;2010: 986310..
   Google Scholar
• Zetterberg H, Nexo E, Regland B, Minthon L, Boson R, Palmer M, Rymo L, Blennow K. The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease. Clin Chem 2003;49:1195–8.
   PubMed Web of Science ®Google Scholar
• Obeid R, Kostopoulos P, Knapp JP, Kasoha M, Becker G, Fassbender K, Herrmann W. Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid. Clin Chem 2007;53:326–33.
   PubMed Web of Science ®Google Scholar
• Seyfert S, Faulstich A, Marx P. What determines the CSF concentrations of albumin and plasma-derived IgG? J Neurol Sci 2004;219:31–3.
   PubMed Web of Science ®Google Scholar
• Roth RB, Hevezi P, Lee J, Willhite D, Lechner SM, Foster AC, Zlotnik A. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 2006;7:67–80.
   PubMed Web of Science ®Google Scholar
• Link H, Tibbling G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest 1977;37:391–6.
   PubMed Web of Science ®Google Scholar
• Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD. Preventing Alzheimer's disease- related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A 2013;110:9523–8.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998; 51:357–62.
   PubMed Web of Science ®Google Scholar